Posted on

Rutgers Recruiting 2,000 Participants for Johnson & Johnson Phase 3 COVID-19 Vaccine Trial

64310182 10156106202320951 9163112232647655424 n

the staff of the Ridgewood blog

New Brunswick NJ, Rutgers University is a clinical trial site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s COVID-19 vaccine candidate.

Continue reading Rutgers Recruiting 2,000 Participants for Johnson & Johnson Phase 3 COVID-19 Vaccine Trial